researchers recommending that clustering be taken into account in the analysis whenever multiple births are present. 1, 3, [5] [6] [7] In contrast, the impact of clustering due to multiple births on the sample size calculation has received little attention. It is important to account for clustering in sample size calculations to ensure trials are appropriately powered, since clustering can reduce the effective sample size. 8, 9 However, clustering due to multiple births is typically ignored when determining the target sample size for perinatal trials. 2 Two main challenges arise when attempting to account for multiple births in sample size calculations. Firstly, an estimate of the strength of the dependence between outcomes of infants from the same birth is required. This is measured by the intracluster correlation coefficient (ICC), which ranges from -1 to 1. 9 An ICC of 0 indicates that outcomes of multiples are independent, and the ICC approaches 1 or -1 as their outcomes become more positively or negatively correlated, respectively. The ICC is rarely reported for trials including multiple births 2 and depends on a number of factors including the target population, study design, type of intervention, estimation method and outcome of interest. 10 ICC estimates for a range of infant outcomes from various trials are therefore needed to assist with sample size calculations for future trials. Secondly, standard sample size calculation methods assume that the outcomes of all infants are independent. Methods have recently been developed that could be used to calculate the sample size for trials including multiple births but currently only apply to twins. These methods have been described in the statistical literature and involve complex equations. 11 To facilitate their use in practice, a more user-friendly presentation of the information required to calculate the sample size in the context of perinatal trials, and a simple tool for calculating the sample size, are needed.
In this article we aim to (1) provide ICC estimates for a range of infant outcomes that are commonly collected in perinatal trials; (2) describe the information that must be specified in order to account for clustering due to twin births in sample size calculations; and (3) provide a simple tool for calculating the target sample size for trials including twin births. Consistent with currently available sample size calculation methods, 11 we restrict our attention in aims 2 and 3 to trials involving singletons and twins, where either mothers or infants are randomised to an intervention or control treatment in a 1:1 ratio, and with a continuous or binary primary outcome that will be analysed using regression models with generalised estimating equation (GEE) estimation to account for clustering due to twins.
Other scenarios, including higher order multiples, are considered in the Comment section.
| ME THODS

| Estimating intracluster correlation coefficients
ICCs were estimated using data from four randomised trials that included infants from a multiple birth: the Docosahexaenoic Acid for the Improvement of Neurodevelopmental Outcomes in Preterm Infants (DINO) Trial, 12 the Bottles, Cups and Dummies (BCD) Trial, 13 the Twins Timing of Birth (TTB) Trial 14 and the n-3 Fatty Acids for Improvement in Respiratory Outcomes (N3RO) Trial. 15 The characteristics of these trials are summarised in Table 1 and a more detailed description is provided in the Appendix S1. ICCs were estimated for a range of infant outcomes (Tables 2 and 3 ). Birthweight z-score and small for gestational age were derived using Australian standards for singletons and twins, 16, 17 and follow-up weight z-score was derived using World Health Organization child growth standards. 18 ICCs were estimated in SAS v9.4 using a linear model for continuous variables, and both a logistic model and a log binomial model for binary variables. A treatment group effect was included in the model for variables measured after randomisation, since ignoring the treatment group can lead to biased ICC estimates, 19 and a single ICC was estimated across both treatment groups. Analyses were performed with and without adjustment for multiple birth status as a fixed effect for the three trials that included infants from both single and multiple births, since multiple birth status is sometimes used as an adjustment variable in the analysis 2 and adjustment can reduce the ICC. 20 Triplets were included in the analysis for the DINO and N3RO trials but were excluded in a sensitivity analysis. TA B L E 1 Characteristics of four randomised trials that included infants from multiple births Clustering due to multiple births was taken into account using GEEs, as this is the most popular estimation method for accounting for this type of clustering 1,2 and has been shown to perform well in this setting. 6 ICCs were estimated based on an exchangeable working correlation structure (no ICC is estimated if an independence structure is specified) and confidence intervals were obtained via bootstrapping using the bias corrected and accelerated method 21 with resampling of clusters.
| Sample size calculations for trials including twins
A general approach for determining the target sample size for any study involving clustered data begins with calculating the sample size using standard methods that assume all outcomes are independent (eg [22] [23] [24] 11 and several design features and parameter estimates must be specified in order to calculate the relevant DEFF. First, the method for randomising twins needs to be decided. If the mother is to receive the treatment then both twins will necessarily be randomised to the same group. If the infant is to receive the treatment then twins may be randomised to the same group (cluster randomisation), independently of each other (individual randomisation) or to opposite treatment groups. Second, the primary outcome needs to be defined, including whether it will be a binary (eg neonatal morbidity) or continuous measure (eg weight). For binary outcomes, the expected outcome prevalence in each treatment group and the effect measure of interest (odds ratio or relative risk, estimated by the logistic or log binomial model, respectively) must also be specified. Third, the approach that will be used to account for clustering in the statistical analysis needs to be chosen. We have focused on GEEs and a simple introduction to this estimation method can be found elsewhere. 25 It requires specification of an assumed pattern of correlation among outcomes for each cluster known as a working correlation structure, and an independence or exchangeable working correlation structure may be chosen for analysing trials including twins. The latter estimates the correlation between outcomes of pairs of members from the same cluster, which is assumed to be constant, while the former assumes this correlation is 0 and accounts for clustering using robust variance estimation. 26 Fourth, an estimate of the twin birth rate for the trial is required. This will vary depending on the population of interest and estimates may be obtained from published trials in similar populations or national birth statistics. Care must be taken to distinguish between the percentage of mothers in a trial who
give birth to twins, and the percentage of infants in a trial who are from a twin birth. For example, in a trial recruiting 100 pregnant women of whom 10 give birth to twins, 10% of women have a twin birth whereas 18% of infants (20 out of 110) are from a twin birth. Either percentage can be used to calculate the DEFF using our sample size tool. Finally, an estimate of the ICC among twins is needed for the primary outcome.
Once these factors have been specified, the DEFF can be calculated by hand using the appropriate equation 11 and used to multiply the sample size obtained assuming independence to produce the target sample size accounting for clustering due to twins. Alternatively,
we have developed a sample size calculator that allows researchers to enter the necessary information into a Microsoft Excel worksheet or R Shiny web app that calculates the DEFF and sample size automatically. Example sample size calculations were performed using Stata v14.2 (assuming all infants are independent) and this calculator.
| RE SULTS
| Intracluster correlation coefficients
ICC estimates obtained from the four example trials are presented in Table 2 for continuous outcomes and Table 3 
| Sample size calculator
A sample size tool that calculates the DEFF and target sample size for randomised trials including twins in Microsoft Excel is provided in the Appendix S2. The calculator is also available as an R Shiny web app at https://djprice.shinyapps.io/gee_ calculator/ and R code for local implementation of the calculator is available at https://github.com/DJPrice10/GEE-Sample-SizeCalculator (Appendix S1). The user must input the information required to calculate the DEFF, including the twin birth rate and the ICC. To illustrate how this calculator and the ICC estimates can be used to determine the target sample size for a future trial, consider the following hypothetical examples. Suppose a trial is planned to assess the effect of a new infant formula designed to improve growth in infants born preterm (<37 weeks' gestation).
The primary outcome is weight z-score at 18 months of age and the new formula is expected to increase the mean z-score by 0.3 compared with standard infant formula. Assuming all infants in the trial will be independent, 235 infants are required per group to have 90% power to detect this increase, based on a two-sample ttest (alpha = 0.05, standard deviation = 1). Suppose, however, that 70% of infants recruited are expected to be from a single birth, while 30% are expected to be from a twin birth. As the intervention will be given to the infants, all methods of randomising twins are possible in this trial. The DEFF was calculated using the sample size calculator with an ICC of 0.58 based on the DINO Trial (Table 2) , since both this trial and the hypothetical trial focus on a preterm population with weight measurements at 18 months.
Assuming the treatment effect will be estimated using GEEs with an independence working correlation structure, the target sample size varies from 195 infants per group if twins are assigned to opposite treatment groups, to 276 infants per group if cluster randomisation is chosen (Appendices S1 and S2).
As a second example, suppose another trial is planned to assess the effect of a dietary intervention given to pregnant women on the percentage of infants born small for gestational age, where the intervention is expected to reduce this from 10%
to 5%. Assuming all infants in the trial will be independent, 621 infants are required per group based on a two-sided continuitycorrected chi-square test (90% power, alpha = 0.05). However, 90% of women recruited are expected to have a single birth, while 10% are expected to have a twin birth. As the intervention will be given to pregnant women, the trial will necessarily use cluster randomisation for twins. The target population for the hypothetical trial is somewhat different to the population included in the four example trials and hence the largest ICC estimate for being small for gestational age across the four trials of 0.36 (Table 3) was chosen to produce the largest sample size, which is most likely to provide adequate power. Using the sample size calculator, the target sample size increases to 662 or 653 infants per group if the analysis will be performed assuming an independence or exchangeable working correlation structure respectively, independent of whether the odds ratio or relative risk is the effect measure of interest (Appendices S1 and S2).
To understand the impact of twins on sample size calculations more generally, the relationship between the ICC and the DEFF is shown in Figure 1 , and the relationship between the ICC and the sample size is shown in the Appendix S1. When the twin birth rate is 3%, which may be expected in the general population of pregnant women, 27 the DEFF is close to 1 and hence twins have little impact on the sample size unless the ICC is relatively large ( Figure 1A ). For a twin birth rate of 20%, which is typical in trials targeting preterm infants, 2 even a small ICC can lead to a DEFF that is substantially different from 1 and hence twins can have a large impact on the target sample size ( Figure 1B ). Assuming the ICC is positive, including twins in a trial results in a larger sample size for cluster randomisation, and the same or a smaller sample size for individual randomisation or randomisation to opposite treatment groups, compared with a trial involving singletons only.
A larger sample size is required if the independence rather than the exchangeable working correlation structure is planned for the analysis. 
TA B L E 2 Intracluster correlation coefficients for continuous outcomes measured in four randomised trials
| COMMENT
| Principal findings
We provide ICC estimates for a range of routinely collected infant outcomes from four randomised trials that included infants from a multiple birth. ICC estimates were generally positive and as high as 0.98. We also describe the information that must be specified in order to calculate the DEFF and hence the sample size for randomised trials including twins, and provide a simple tool to perform the calculations automatically. Our example sample size calculations demonstrate that the inclusion of twins can have a substantial impact on the target sample size.
| Interpretation
We found substantial variation in ICC estimates between outcomes and across trials, which may be due to differences in the outcome measure, study setting, and inclusion/exclusion criteria.
We also found that confidence intervals for ICC estimates were relatively wide, even for the N3RO trial with over 1200 partici- The target sample size can vary considerably depending on how twins will be randomised. Assuming the ICC is positive, assigning twins to different treatment groups requires the smallest sample size but may make recruitment challenging, since it is the least favoured method among parents of twins. 28 Cluster randomisation is the most common randomisation approach used in perinatal trials, 1,2 is preferred by parents 28 and is the only option for treatments given to the mother, but it also requires the largest sample size. Where feasible, individual randomisation may provide a good compromise by requiring a smaller sample size than cluster randomisation and being more acceptable to parents than randomisation to different groups. 28 To calculate the sample size for a trial that will be analysed using regression models with GEE estimation, a decision must be made between assuming an independence or exchangeable working correlation structure. Although the exchangeable working correlation structure is more realistic, requires a smaller sample size 11 and may result in a more efficient analysis, 29, 30 it is prone to convergence problems 11 and may not produce treatment effect estimates with a meaningful interpretation. 31 We therefore recommend assuming an independence working correlation structure for sample size planning and analysis.
When the outcome of interest is binary, the target sample size can vary depending on whether the treatment effect of interest is the odds ratio or the relative risk, although differences will generally be small. The relative risk is popular due to the ease of interpretation but convergence problems can occur when fitting the log binomial model. These can easily be overcome using a modified Poisson approach 32 that remains valid for clustered data. 33 As the log binomial and modified Poisson regression models have similar performance when both converge, 33 we expect sample size calculations based on the log binomial model will provide the desired power if the final analysis is performed using modified Poisson regression.
F I G U R E 1
Relationship between the intracluster correlation coefficient (ICC) and the design effect for a continuous outcome by method of randomising twins (cluster randomisation, individual randomisation or randomisation to opposite treatment groups) when A, 3% or B, 20% of mothers have a twin birth. Black and grey lines indicate scenarios where the independence and exchangeable working correlation structures will be assumed in the analysis, respectively
Although this study focused on randomised trials including twins, our findings will be helpful for sample size planning in other settings.
For trials involving higher order multiples, ignoring them and using the sample size calculator to account for twins may give a reasonable approximation, provided higher order multiples are expected to be rare. Alternatively, new DEFF equations could be derived that allow for higher order multiples and this is an important area for future research. For observational studies involving twins, the ICC estimates remain relevant but the sample size calculator is currently limited to scenarios where the exposure of interest is binary with 50% prevalence (as is the case in randomised trials with two treatment groups and a 1:1 allocation ratio).
| Strengths of the study
This study provides ICC estimates for a range of outcomes from multiple trials conducted using different methods of randomisation in different populations, thus allowing researchers to choose the most relevant ICC estimate for planning future trials. It also provides the first sample size tool that can be used to account for twins in sample size calculations automatically.
| Limitations of the data
Our study has several limitations. First, zygosity was not considered in the ICC calculations, since this information was not collected in the example trials. ICCs may be higher for monozygous compared to dizygous twins 34 and future studies collecting zygosity could report ICCs separately for these subgroups. Second, the sample size calculator assumes the analysis will be performed using regression models with GEE estimation. Further research is needed to determine whether the calculator is suitable to use when other analysis approaches are planned, such as mixed effects models, due to potential differences in power. Third, we only present ICC estimates from four trials and many outcomes were not available for all trials or were based on a neurodevelopmental assessment tool that has since been updated. Additional published ICCs are needed. Finally, sample size methods for survival and count outcomes were not considered and this is an interesting area for future work.
| CON CLUS IONS
Clustering due to twins should be taken into account in sample size calculations for perinatal trials to obtain the desired power. We have shown how to achieve this by multiplying the sample size obtained assuming independence by an appropriate DEFF using our calculator. We have also reported ICC estimates that can be used to inform the sample size for future trials. Publication of ICCs for additional infant outcomes and from a broader range of studies is needed to further assist with sample size planning for future trials including twins.
